They suggested that the activation of PGE2/EP2 and PGE2/EP4 signaling may positively regulate the expression level of PD-1 in infiltrating CD8+ T cells to result in the immune tolerance in the TME of lung cancer [72]. The gene discussed is CD8A; the disease is lung cancer.